UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long‐Established Target Mitochondrial Pyruvate Carrier
Abstract Targeting NLRP3 inflammasome has been recognized as a promising therapeutic strategy for the treatment of numerous common diseases. UK5099, a long‐established inhibitor of mitochondrial pyruvate carrier (MPC), is previously found to inhibit macrophage inflammatory responses independent of M...
Shranjeno v:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2024-09-01
|
| Serija: | Advanced Science |
| Teme: | |
| Online dostop: | https://doi.org/10.1002/advs.202307224 |
| Oznake: |
Brez oznak, prvi označite!
|
